US-based drug maker Moderna Incorporated says it has received an additional US$472 million from the U.S. government's Biomedical Advanced Research and Development Authority to support development of its coronavirus vaccine.
Moderna said the additional funding will support its late-stage clinical development including the expanded Phase 3 study of its vaccine candidate.
In April, Moderna received $483 million from the U.S. federal agency that funds disease-fighting technology, when the experimental vaccine was in an early-stage trial conducted by the U.S. National Institutes of Health.
According to the company the Phase 3 study, conducted in collaboration with the National Institute of Allergy and Infectious Diseases, will begin today and involve about 30,000 participants.
Moderna said it remains on track to be able to deliver about 500 million doses per year, and possibly up to 1 billion doses per year, beginning in 2021.
Advertisement
Moderna Incorporated receives additional funds to develop COVID-19 vaccine
11:20 am, Mon July 27, 2020
More Stories
Advertisement
Most Popular
Reggae Boys to open final round World Cup...
9:59 pm, Sat July 12, 2025
9:59 pm, Sat July 12, 2025
Windies bowlers produce excellent performance...
10:01 pm, Sat July 12, 2025
10:01 pm, Sat July 12, 2025
Regional private sector body welcomes...
10:39 pm, Sat July 12, 2025
10:39 pm, Sat July 12, 2025
Advertisement

Advertisement
Advertisement
Advertisement